N/A
Completed N=121
AcrySof IQ Toric A-Code Post-Market Clinical Study
Cataract · Astigmatism
Source: ClinicalTrials.gov NCT03350503 ↗
Enrolled (actual)
121
Serious AEs
12.4%
Results posted
May 2020
Primary outcomePrimary: Percentage of Eyes With Absolute Value of Intraocular (IOL) Rotation (Visit 00 to Visit 4) — 99.1; 0.9; 100.0; 0.0 percentage of eyes
Summary
The purpose of this study is to clinically confirm the rotational stability of a modified AcrySof IQ toric intraocular lens (IOL) in a Japanese population.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Eyes With Absolute Value of Intraocular (IOL) Rotation (Visit 00 to Visit 4) |
99.1; 0.9; 100.0; 0.0; 100.0; 0.0 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of cataracts with planned cataract removal by phacoemulsification
- Calculated lens power within the available range
- Able to sign informed consent and complete all study visits
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria
- Eye conditions as specified in the protocol
- Uncontrolled glaucoma
- Pregnancy, current or planned
- Other protocol-defined exclusion criteria may apply.
Data sourced from ClinicalTrials.gov (NCT03350503). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.